Biofarm S.A. (BVB: BIO)

Market Cap	717.35M
Revenue (ttm)	282.13M
Net Income (ttm)	80.32M
Shares Out	985.37M
EPS (ttm)	0.07
PE Ratio	9.79
Forward PE	n/a
Dividend	0.03 (4.26%)
Ex-Dividend Date	Aug 20, 2024

Volume	2,141
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	0.660 - 0.910
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 28, 2025

About Biofarm

Biofarm S.A. engages in the manufacture and sale of medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan...

• Industry: Pharmaceutical Preparations
• Founded: 1921
• Employees: 399
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: BIO

Financial Performance

In 2023, Biofarm's revenue was 280.29 million, an increase of 1.19% compared to the previous year's 276.98 million. Earnings were 77.01 million, an increase of 8.60%.